NCT04839718

Brief Summary

Depression and anxiety are increasingly common conditions for which primary care providers (PCPs) serve as the initial healthcare contact for most patients. Comorbid depression and anxiety result in higher costs, and treatment as usual, which is referrals to specialty psychiatric care, often contribute to delays in care. Collaborative psychiatric care is an evidence-based strategy to increase mental healthcare access while reducing costs. ADAPT is a novel collaborative care model. By using technology-driven appointments with providers, ADAPT increases access to mental healthcare, and reduces member wait times. This mixed methods study will assess implementation measures of the ADAPT program and the components of ADAPT related to patient mental health improvement compared to specialty mental health care. The hypothesis is that: ADAPT program will have good program reach and efficacy. We will examine program implementation and maintenance. Further, the study looks to uncover member and program characteristics that are associated with depression and anxiety remission and care utilization.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 9, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

March 2, 2023

Status Verified

February 1, 2023

Enrollment Period

3.8 years

First QC Date

March 29, 2021

Last Update Submit

February 28, 2023

Conditions

Keywords

DepressionAnxiety

Outcome Measures

Primary Outcomes (1)

  • Patient reach

    Examine and compare patients eligible and enrolled in ADAPT versus those eligible but not enrolled in ADAPT

    through study completion, 2 years

Secondary Outcomes (14)

  • Member characteristics associated with depression remission

    baseline, 3 and 6 months

  • Member characteristics associated with anxiety remission

    baseline, 3 and 6 months

  • Efficacy: Patient therapy engagement

    baseline, 3 and 6 months

  • Efficacy: Patient medication provider engagement

    baseline, 3 and 6 months

  • Efficacy: Patient medication engagement

    baseline, 3 and 6 months

  • +9 more secondary outcomes

Study Arms (2)

Control

Patients receiving referral to specialty mental healthcare

ADAPT

ADAPT

Behavioral: ADAPT

Interventions

ADAPTBEHAVIORAL

The Achieving Depression and Anxiety Patient Centered Treatment (ADAPT) Program is a novel collaborative psychiatric care model that is designed to unburden PCPs and psychiatrists, increase access to quality specialty mental healthcare for Kaiser Permanente members, and improve patient depression and anxiety treatment outcomes by utilizing technology-driven appointments. This program uses principles of collaborative care, including patient-centered care, population-based care, evidence-based care, measurement-based treatment to target, and accountable care.

ADAPT

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Kaiser Permanente Northern California adult members who screen positive for depression or anxiety in primary care and are referred to treatment.

You may qualify if:

  • Adult Outcomes Questionnaire (AOQ) score between 10-30
  • English-Speaking

You may not qualify if:

  • High risk for suicide defined by answer to question 9 on PHQ-9 of 1 or more
  • Diagnosis of bipolar disorder
  • Diagnosis of a psychotic disorder
  • Dementia diagnosis
  • Active substance use disorder diagnosis
  • Current hospice
  • Current home-based palliative care
  • Residing in a skilled nursing facility
  • Residing in an assisted living facility
  • Non-Kaiser Permanente Member
  • Established psychiatric care outside of Kaiser Permanente

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaiser Permanente Northern California Division of Research

Oakland, California, 94612, United States

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Officials

  • Kathryn K Erickson-Ridout, MD PhD

    Kaiser Permanente

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2021

First Posted

April 9, 2021

Study Start

April 1, 2019

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

March 2, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations